Vaccine against RSV

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9125870
APP PUB NO 20140147463A1
SERIAL NO

13849380

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype 26 that comprises nucleic acid encoding a RSV F protein or immunologically active part thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CRUCELL HOLLAND B VLEIDEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Custers, Jerome H H V Alphen aan den Rijn, NL 4 84
Radosevic, Katarina Leiden, NL 23 227
Vellinga, Jort Leiden, NL 18 114
Widjojoatmodjo, Myra N Leiden, NL 6 66

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00